Investor Alley Inc.

Mid-Day Follow-Up Commentary on Selected Picks: (NASDAQ:ACAD), (NYSE:MTG)


New York, NY -- (ReleaseWire) -- 01/23/2013 --Pharmaceuticals Inc. (NASDAQ:ACAD) stock is at $5.81, up 2.45 percent from its previous close of $5.67. However, its today’s volume of 3.809 million shares is higher than its usual trading volume of 3.237 million shares. The stock opened the session at $6.00 and touched its highest price point at $6.19. Acadia Pharmaceuticals stock’s lowest price point for the session stood at $5.80. The stock’s MACD chart shows bullish trend in the short term. Its first resistance level is at $6.50. Acadia Pharmaceuticals develops small molecule drugs for treating neurological disorders.

Find out more on ACAD by getting the free trend analysis report here:

MGIC Investment Corp. (NYSE:MTG) is trading in the range of $3.04 and $3.33 during its latest trading session. The stock recorded the volume of 7.115 million shares, significantly higher than its average daily trading volume of 4.257 million shares. Its uptick accompanied by higher volume shows bullish trend, which is further confirmed by its MACD and EMA charts. The stock had opened at $3.04 and is at $3.25, up 8.78 percent from its previous close of $2.99. MGIC Investment offers mortgage insurance products. The company is based out of Wisconsin and also provides risk sharing arrangements.

Find out more on MTG by getting the free trend analysis report here:

About issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.

BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

Contact Info:
Michael Baine